These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33257736)

  • 1. Topical delivery of a small molecule RUNX1 transcription factor inhibitor for the treatment of proliferative vitreoretinopathy.
    Delgado-Tirado S; Amarnani D; Zhao G; Rossin EJ; Eliott D; Miller JB; Greene WA; Ramos L; Arevalo-Alquichire S; Leyton-Cifuentes D; Gonzalez-Buendia L; Isaacs-Bernal D; Whitmore HAB; Chmielewska N; Duffy BV; Kim E; Wang HC; Ruiz-Moreno JM; Kim LA; Arboleda-Velasquez JF
    Sci Rep; 2020 Nov; 10(1):20554. PubMed ID: 33257736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Effects of Fucoidan on Epithelial-Mesenchymal Transition of Retinal Pigment Epithelial Cells and Progression of Proliferative Vitreoretinopathy.
    Zhang Y; Zhao D; Yang S; Yao H; Li M; Zhao C; Zhang J; Xu GT; Li H; Wang F
    Cell Physiol Biochem; 2018; 46(4):1704-1715. PubMed ID: 29698960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol inhibits epithelial-mesenchymal transition of retinal pigment epithelium and development of proliferative vitreoretinopathy.
    Ishikawa K; He S; Terasaki H; Nazari H; Zhang H; Spee C; Kannan R; Hinton DR
    Sci Rep; 2015 Nov; 5():16386. PubMed ID: 26552368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMP7 antagonizes proliferative vitreoretinopathy through retinal pigment epithelial fibrosis in vivo and in vitro.
    Yao H; Ge T; Zhang Y; Li M; Yang S; Li H; Wang F
    FASEB J; 2019 Mar; 33(3):3212-3224. PubMed ID: 30383450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potential role for PDGF-C in experimental and clinical proliferative vitreoretinopathy.
    Lei H; Hovland P; Velez G; Haran A; Gilbertson D; Hirose T; Kazlauskas A
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2335-42. PubMed ID: 17460299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Proliferative Vitreoretinopathy Is Attenuated by Chicken Ovalbumin Upstream Promoter Transcriptional Factor 1 Via Inhibiting Epithelial-Mesenchymal Transition.
    Jin H; Cai W; Yu D; Fan J; Liu Q; Yu J
    Discov Med; 2022; 34(172):103-113. PubMed ID: 36333112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of TGF-ß1 in experimental proliferative vitreoretinopathy is accompanied by epithelial to mesenchymal transition.
    Hoerster R; Muether PS; Vierkotten S; Hermann MM; Kirchhof B; Fauser S
    Graefes Arch Clin Exp Ophthalmol; 2014 Jan; 252(1):11-6. PubMed ID: 23680864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DAPL1 prevents epithelial-mesenchymal transition in the retinal pigment epithelium and experimental proliferative vitreoretinopathy.
    Ma X; Han S; Liu Y; Chen Y; Li P; Liu X; Chang L; Chen YA; Chen F; Hou Q; Hou L
    Cell Death Dis; 2023 Feb; 14(2):158. PubMed ID: 36841807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL3 attenuates proliferative vitreoretinopathy and epithelial-mesenchymal transition of retinal pigment epithelial cells via wnt/β-catenin pathway.
    Ma X; Long C; Wang F; Lou B; Yuan M; Duan F; Yang Y; Li J; Qian X; Zeng J; Lin S; Shen H; Lin X
    J Cell Mol Med; 2021 May; 25(9):4220-4234. PubMed ID: 33759344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated Blood Coagulation Factor X (FXa) Contributes to the Development of Traumatic PVR Through Promoting RPE Epithelial-Mesenchymal Transition.
    Han H; Zhao X; Liao M; Song Y; You C; Dong X; Yang X; Wang X; Huang B; Du M; Yan H
    Invest Ophthalmol Vis Sci; 2021 Jul; 62(9):29. PubMed ID: 34283209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Periostin in the Pathogenesis of Proliferative Vitreoretinopathy].
    Ishikawa K
    Nippon Ganka Gakkai Zasshi; 2015 Nov; 119(11):772-80. PubMed ID: 26685481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch signaling modulates proliferative vitreoretinopathy via regulating retinal pigment epithelial-to-mesenchymal transition.
    Zhang J; Yuan G; Dong M; Zhang T; Hua G; Zhou Q; Shi W
    Histochem Cell Biol; 2017 Mar; 147(3):367-375. PubMed ID: 27600720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA ERLR mediates epithelial-mesenchymal transition of retinal pigment epithelial cells and promotes experimental proliferative vitreoretinopathy.
    Yang S; Li H; Yao H; Zhang Y; Bao H; Wu L; Zhang C; Li M; Feng L; Zhang J; Zheng Z; Xu G; Wang F
    Cell Death Differ; 2021 Aug; 28(8):2351-2366. PubMed ID: 33664479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial-mesenchymal transition suppresses ERas to activate autophagy in retinal pigment epithelial cells in proliferative vitreoretinopathy.
    Pan J; Zhao LX
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4627-4634. PubMed ID: 32432726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Curcumin on Epidermal Growth Factor in Proliferative Vitreoretinopathy.
    Ren YX; Ma JX; Zhao F; An JB; Geng YX; Liu LY
    Cell Physiol Biochem; 2018; 47(5):2136-2146. PubMed ID: 29975931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered Decorin Biology in Proliferative Vitreoretinopathy: A Mechanistic and Cohort Study.
    Begum G; O'Neill J; Chaudhary R; Blachford K; Snead DRJ; Berry M; Scott RAH; Logan A; Blanch RJ
    Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):4929-4936. PubMed ID: 30347087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Effect of Everolimus on Retinal Pigment Epithelial Cells and Experimental Proliferative Vitreoretinopathy.
    Kuo HK; Chen YH; Kuo YH; Ke MC; Tseng YC; Wu PC
    Curr Eye Res; 2018 Mar; 43(3):333-339. PubMed ID: 29182404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yes-associated protein is essential for proliferative vitreoretinopathy development via the epithelial-mesenchymal transition in retinal pigment epithelial fibrosis.
    Zhang W; Li J
    J Cell Mol Med; 2021 Nov; 25(21):10213-10223. PubMed ID: 34598306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribozyme to proliferating cell nuclear antigen to treat proliferative vitreoretinopathy.
    Mandava N; Blackburn P; Paul DB; Wilson MW; Read SB; Alspaugh E; Tritz R; Barber JR; Robbins JM; Kruse CA
    Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3338-48. PubMed ID: 12356843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repression of Smad4 by MicroRNA-1285 moderates TGF-β-induced epithelial-mesenchymal transition in proliferative vitreoretinopathy.
    Pao SI; Lin LT; Chen YH; Chen CL; Chen JT
    PLoS One; 2021; 16(8):e0254873. PubMed ID: 34383767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.